Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Evotec Se (EVOTF)

Evotec Se (EVOTF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow 67.93
  • Price/Book 2.64
Trade EVOTF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.6875 unch
on 11/21/22
17.1073 -2.45%
on 11/18/22
-0.5225 (-3.04%)
since 09/22/22
3-Month
16.6875 unch
on 11/21/22
20.0850 -16.92%
on 09/16/22
-11.7125 (-41.24%)
since 08/03/22
52-Week
16.6875 unch
on 11/21/22
49.1900 -66.08%
on 12/16/21
-30.8725 (-64.91%)
since 11/19/21

Most Recent Stories

More News
Evotec Enters a Drug Discovery Collaboration with Janssen

HAMBURG, GERMANY / ACCESSWIRE / June 14, 2022 / Evotec SE (FRA:EVT)(MDAX/TecDAX)(ISIN:DE0005664809)(NASDAQ:EVO) announced today that the Company has entered a drug discovery collaboration with Janssen...

EVOTF : 16.6875 (-2.45%)
EVT : 24.20 (-1.59%)
EVO : 8.76 (-4.16%)
Evotec and Almirall Enter into a Multi-Target Alliance in Medical Dermatology

HAMBURG, GERMANY and BARCELONA, SPAIN / ACCESSWIRE / May 19, 2022 / Evotec SE (Frankfurt Stock Exchange:EVT)(MDAX/TecDAX, ISIN: DE0005664809)(NASDAQ:EVO) and Almirall S.A. (ALM), a global biopharmaceutical...

EVOTF : 16.6875 (-2.45%)
EVT : 24.20 (-1.59%)
EVO : 8.76 (-4.16%)
Evotec SE Fiscal Year 2021 Results: 'Setting the Pace' on the Data-Driven R&D Autobahn to Cures

- STRONG FINANCIAL RESULTS: 23% INCREASE IN GROUP REVENUES SIGNIFICANTLY EXCEEDING GUIDANCE - DATA-DRIVEN PLATFORMS AND TECHNOLOGIES INCREASE PROBABILITIES OF SUCCESS IN ALL MODALITIES - SUBSTANTIALLY...

EVOTF : 16.6875 (-2.45%)
EVO : 8.76 (-4.16%)
Evotec Achieves Programme Designation in Neuroscience Collaboration with Bristol Myers Squibb

- THE PROGRAMME DESIGNATION IS BASED ON AN ANTISENSE-BASED APPROACH WHICH TRIGGERS A US$ 16 M PAYMENT TO EVOTEC BY BRISTOL MYERS SQUIBB - EVOTEC SOURCES LNAPLUS(TM) ANTISENSE TECHNOLOGY THROUGH A STRATEGIC...

EVOTF : 16.6875 (-2.45%)
EVO : 8.76 (-4.16%)
Evotec Receives € 7.5 m Grant for Development of COVID-19 Therapeutic

- EVOTEC RECEIVES A € 7.5 M GRANT FROM THE GERMAN FEDERAL MINISTRY OF EDUCATION AND RESEARCH ("BMBF") FOR THE DEVELOPMENT OF A THERAPEUTIC AGAINST COVID-19 - EVOTEC IS DEVELOPING A HIGHLY POTENT IMMUNOMODULATORY...

EVOTF : 16.6875 (-2.45%)
EVT : 24.20 (-1.59%)
EVO : 8.76 (-4.16%)

Key Turning Points

3rd Resistance Point 16.6875
2nd Resistance Point 16.6875
1st Resistance Point 16.6875
Last Price 16.6875
1st Support Level 16.6875
2nd Support Level 16.6875
3rd Support Level 16.6875

See More

52-Week High 49.1900
Fibonacci 61.8% 36.7740
Fibonacci 50% 32.9388
Fibonacci 38.2% 29.1035
Last Price 16.6875
52-Week Low 16.6875

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar